Bullish & Foolish
Full IVVD fundamentals All 466 on the Survival Watch

IVVDINVIVYD, INC.

Is Invivyd struggling financially?

Yes, by its own account. Invivyd told the SEC on 14 May 2026, in Form 10-Q, that there is substantial doubt about its ability to continue as a going concern.

Going concern disclosed May 2026

30/100

Fragile

Sector
Biotech/Pharma
Market cap
$293.7M
Source filing
10-Q 14 May 2026
Balance sheet
30 Jun 2026

Cash runway

28+ mo

Runs out some time after Oct 2028, raising nothing.

Out of cashTwo years or more

The runway math

Cash and short-term investments

$160.1M

÷

Cash burned over the last 12 months

$58.3M

What Invivyd told the SEC

…qualified employees, and reliance on third-party organizations for the discovery, manufacturing, clinical and commercial success of its product candidates. Substantial Doubt about Ability to Continue as a Going Concern The accompanying condensed consolidated financial statements have been prepared on the basis of continuity of operations, realization of assets, and the satisfaction of liabilities and…

INVIVYD, INC., Form 10-Q, filed 14 May 2026.

Read the filing on SEC.gov

What this means

  • Not a bankruptcy filing, and not a prediction.
  • It is the company’s own statement, agreed with its auditor, that the doubt is material enough to disclose.
  • The runway is arithmetic on two reported numbers, not a forecast. Companies carry this language for years, raise money and keep going.

What else the numbers show

  • 162.7% share-count increase The company issued stock. Each share now owns 61.9% less of the business than a year ago, before any change in the price.
  • Cash burn is narrowing It is spending 74% less cash per year than it was, so the runway above is lengthening rather than shortening.

Other Biotech/Pharma companies that filed the doubt